U.S. to Invest $3.2b to Develop Antiviral Pills for Covid: NYT

June 17, 2021, 2:48 PM

The U.S. government is investing $3.2 billion to develop antiviral pills for Covid-19, the New York Times reports, citing an announcement from the Department of Health and Human Services.

  • Some pills could be available by the end of the year
  • Government considering AT-527, developed by Atea Pharmaceuticals
    • Atea shares up Thursday as much as 13.6%
  • Drug created by Pfizer scientists on government’s radar
  • Antiviral Program for Pandemics to support research for new drugs, not just for the coronavirus

To contact the reporter on this story:
Luke McGrath in New York at lmcgrath18@bloomberg.net

To contact the editors responsible for this ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.